The objective of this initiative is to enhance treatment accessibility for HR positive/HER2 negative advanced breast cancer patients in low and middle-income nations. The founding partners of the Humanitarian PACT for ABC consist of the ABC Global Alliance, the American Society of Clinical Pathology, Cepheid, and Novartis AG.
Learn MoreIn the near future, we will release a press statement revealing the countries selected for the 2023 program.